Cytokinetics, Incorporated (CYTK)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 65.27 |
| Open | 68.21 |
| Bid | 64.00 x 300 |
| Ask | 64.09 x 100 |
| Day's range | 61.75 - 68.44 |
| 52-week range | 25.98 - 110.25 |
| Volume | |
| Avg. volume | 1,926,919 |
| Market cap | 6.695B |
| Beta (5Y monthly) | 0.72 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -5.40 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 93.88 |
Insider MonkeyCytokinetics, Incorporated (NASDAQ:CYTK) Q1 2024 Earnings Call Transcript
Cytokinetics, Incorporated (NASDAQ:CYTK) Q1 2024 Earnings Call Transcript May 9, 2024 Cytokinetics, Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. And welcome ladies and gentlemen to Cytokinetics First Quarter 2024 Conference Call. [Operator Instructions] I will now […]
- GuruFocus.com
Cytokinetics Inc (CYTK) Q1 2024 Earnings Call Transcript Highlights: Navigating Through ...
Insights into financial health, R&D progress, and strategic preparations for upcoming FDA submissions.
ZacksCytokinetics (CYTK) Reports Q1 Loss, Lags Revenue Estimates
Cytokinetics (CYTK) delivered earnings and revenue surprises of -14.66% and 26.43%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.